AtaCor Medical announced today that it entered a financing worth up to $75 million to support its U.S. FDA pivotal study.

The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

Treatment includes preventive measures such as reducing fever and avoiding medications that might trigger arrhythmia ...

A woman saved her mum’s life after she suddenly "slumped" on the sofa. Sian Lawson, 55, was watching television when she was ...

Belgium's AZ Maria Middelares is proud to take on a pioneering role as a technology-driven health care organization.

The 30-year-old defender has not played a competitive match for club or country since collapsing on the field on December 16, ...

Motorists struggling with one of 188 medical conditions must inform the DVLA or risk facing fines of up to £1,000. Those ...

Former Premier League boss Iain Dowie has stumbled into serious financial issues and now has a hearing scheduled at the High Court 15 years after his last job in football ...

The implantable defibrillator market is poised for healthy growth through 2035, fueled by the rising global incidence of ...

Governor Matt Meyer signed House Bill 71, requiring all coaches in Delaware to be trained in CPR, first aid and the use of ...

A daughter has shared her father’s experience of a life-changing heart attack that has caused him lifelong complications.